ESA

DRUG5 trials

Sponsors

University Hospital, Basel, Switzerland, Hoffmann-La Roche, Ain Shams University, Kind Pharmaceuticals LLC

Conditions

Anemia Due to Chronic Kidney DiseaseAnemia in End Stage Renal DiseaseChronic Kidney DiseasesRenal Anemia

Phase 1

Study of Rule-Based Algorithms in Anemia Management in Prevalent Hemodialysis Patients and Its Relation to Patients' Outcomes

Active, not recruitingNCT06996717

Ain Shams UniversityAnemia in End Stage Renal Disease

Start: 2025-01-01End: 2025-06-30Target: 145Updated: 2025-05-30

Phase 3

A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

RecruitingNCT07487727

Kind Pharmaceuticals LLCAnemia Due to Chronic Kidney Disease

Start: 2025-12-03End: 2027-07-01Target: 240Updated: 2026-03-27

A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia

RecruitingNCT07494409

Kind Pharmaceuticals LLCAnemia Due to Chronic Kidney Disease

Start: 2025-10-31End: 2027-04-30Target: 300Updated: 2026-03-27

Phase 4

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

CompletedNCT01306409

University Hospital, Basel, SwitzerlandRenal Anemia

Start: 2011-01-31End: 2011-10-31Updated: 2011-10-19

Unknown Phase

Survey on Anemia Therapy in Participants With Chronic Kidney Disease (CKD) Not on Dialysis

CompletedNCT02238067

Hoffmann-La RocheChronic Kidney Diseases

Start: 2011-09-30End: 2013-08-31Updated: 2017-03-24